期刊文献+

医用葡聚糖磁性纳米微粒的制备及特性研究 被引量:4

Preparation and Characteristics of Dextran-coated Iron Oxide Nanoparticle
下载PDF
导出
摘要 目的制备磁响应性强、粒径小且分布均匀的磁性纳米微粒,为消化道恶性肿瘤的磁控靶向治疗提供一种新型载体。方法利用超声波的粉碎空化作用,采用化学共沉淀法合成葡聚糖磁性纳米微粒。通过扫描电镜和原子力显微镜观察微粒的形态和大小,激光光散射粒度分析仪检测微粒的粒径及分布,磁强计检测微粒的磁响应性。结果该法制备的葡聚糖磁性微粒多呈球形或椭圆形,有效粒径为(93.1±2.2)nm,半峰宽为(26.7±1.3)nm,显示其粒径为纳米级,且大小均一。在外加场强为104Oe、外部温度为18℃的条件下微粒的磁响应强度为(26.0±1.1)emu/g,撤除磁场时剩磁为零,提示微粒具有顺磁性。结论用该法制备的葡聚糖磁性微粒,具有有效粒径小、粒径分布窄以及磁响应性好的优点,可作为一种新型靶向磁性载体,进行恶性肿瘤的磁控靶向治疗。 Objective To improve the method of synthesizing magnetic particles, which have good magnetic property and small size, to be used in tumor target therapy. Methods Dextran-coated iron oxide nanoparticles (DCIONPs) were prepared by ultrasonic and chemical coprecipitation method and the characteristics were evaluated. The size and shape of the particles were verified by scanning electron microscope (SEM), the effective diameter and diameter distribution were determined by particle size analyzer, the morphology was investigated by atomic force microscope (AFM), and the magnetic property was evaluated by magnetometer. Results Most of the DCIONPs showed shape of sphere or oval. The effective diameter was (93. 1±2.2) nm, the half width was (26.7±1.3) nm, as indicated that the DCI()NPs were tiny and in conform size, The magnetic response was (26.0± 1.1 ) emu/g in a magnetic field of 104 Oe and the remanence was zero without it, suggesting the nanoparticles' paramagnetism. Conclusion The DCIONPs prepared by ultrasonic coprecipitation method have the advantages of small size, nar row distribution and good magnetic property, and can be used as the magnetic carrier for drug or gene target delivery.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2006年第5期653-655,共3页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家"863"计划资助项目(No.2001AA218051)
关键词 葡聚糖 纳米微粒 靶向治疗 dextran magnetic nanoparticle target therapy
  • 相关文献

参考文献10

  • 1HAFELI U O,GAYLE J P.In vitro and in vivo toxicity of magnetic microspheres[J].J Magn Magn Mater,1999,194(1):76-82.
  • 2王国斌,夏泽锋,陶凯雄,周立国,刘敬伟,肖勇,李剑星.医用纳米级Fe_3O_4磁流体的急性毒理学实验研究[J].华中科技大学学报(医学版),2004,33(4):452-454. 被引量:14
  • 3STEFAN O.Ferrofluids:magnetically controllable liquids[J].Proc Appl Math Mech,2002,1(1):28-32.
  • 4HILGER I,FRUHAUF K,ANDRA W,et al.Heating potential of iron oxides for therapeutic purposes in interventional radiology[J].Acad Radiol,2002,9(2):198-202.
  • 5DENKBAS E B,KILICAY E,BIRLIKSEVEN C,et al.Magnetic chitosan microspheres:preparation and characterization[J].Reac Func Polym,2002,50(3):225-232.
  • 6WAGNER S,SCHNORR J,PILGRIMM H,et al.Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging:preclinical in vivo characterization[J].Invest Radiol,2002,37(4):167-177.
  • 7LAWACZECK R,BAUER H,FRENZEL T,et al.Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting[J].Acta Radiol,1997,38(4 Pt 1):584-597.
  • 8THOREN L.The dextrans-clinical data[J].Devel Biol Stand,1981,48:157-167.
  • 9JANES K A,CALVO P,ALONSO M J.Polysaccharide colloidal particles as delivery systems for macromolecules[J].Adv Drug Deliv Rev,2001,47(1):83-97.
  • 10REZA M.Recent trends in the use of polysaccharides for improved delivery of therapeutic agents:pharmacokinetics and pharmacodynamic perspectives[J].Curr Pharm Biotechnol,2003,4(5):283-302.

二级参考文献12

  • 1Lubbe A S, Bergemann C, Riess H et al. Clinical experiences with magnetic drug targeting: a phase Ⅰ study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res, 1996, 56:4686
  • 2Susan E M, Colin W P, Michael D T. Macromolecular systems for chemotherapy and magnetic resonance imaging. Adv Drug Deliv Rev, 1996, 18:219
  • 3Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug DelivRev, 2003, 55:329
  • 4Goodwin S C, Bittner C A, Peterson C L et al. Singledose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. Toxicol Sci, 2001, 60:177
  • 5Jordan A, Scholz R, Wust P et al. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinomainvivo. Int J Hyperthermia, 1997, 13:587
  • 6Guidance for industry. single dose acute toxicity testing for pharmaceuticals. CEDR, 1996. 1~2
  • 7Toxicokinetics: the assessment of systemic exposure in toxicity studies. CEDR, 1995. 9~10
  • 8WHO food additives series 6: toxicological evaluation of some food colours, enzymes, flavours enhancers, thickening agents and certain food additives. WHO, 1974.
  • 9Hafeli U O, Gayle J P. In vitro and in vivo toxicity of magnetic microspheres. JMMM, 1999, 194:76
  • 10Wagner S, Schnorr J, Pilgrimm H et al. Monomer coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest Radiol, 2002,37: 167

共引文献13

同被引文献34

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部